Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases.

Carlsson A, Wingren C, Kristensson M, Rose C, Fernö M, Olsson H, Jernström H, Ek S, Gustavsson E, Ingvar C, Ohlsson M, Peterson C, Borrebaeck CA.

Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14252-7. doi: 10.1073/pnas.1103125108. Epub 2011 Aug 15.

PMID:
21844363
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
3.

CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients.

Dietrich D, Krispin M, Dietrich J, Fassbender A, Lewin J, Harbeck N, Schmitt M, Eppenberger-Castori S, Vuaroqueaux V, Spyratos F, Foekens JA, Lesche R, Martens JW.

BMC Cancer. 2010 Jun 1;10:247. doi: 10.1186/1471-2407-10-247.

PMID:
20515469
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.

Gong Y, Booser DJ, Sneige N.

Cancer. 2005 May 1;103(9):1763-9.

PMID:
15786420
[PubMed - indexed for MEDLINE]
Free Article
5.

Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer.

Jankowitz RC, Cooper K, Erlander MG, Ma XJ, Kesty NC, Li H, Chivukula M, Brufsky A.

Breast Cancer Res. 2011 Oct 14;13(5):R98. doi: 10.1186/bcr3038.

PMID:
21999244
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy.

Bartlett JM, Thomas J, Ross DT, Seitz RS, Ring BZ, Beck RA, Pedersen HC, Munro A, Kunkler IH, Campbell FM, Jack W, Kerr GR, Johnstone L, Cameron DA, Chetty U.

Breast Cancer Res. 2010;12(4):R47. doi: 10.1186/bcr2604. Epub 2010 Jul 8.

PMID:
20615243
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Autoantibodies as potential biomarkers for breast cancer.

Zhong L, Ge K, Zu JC, Zhao LH, Shen WK, Wang JF, Zhang XG, Gao X, Hu W, Yen Y, Kernstine KH.

Breast Cancer Res. 2008;10(3):R40. doi: 10.1186/bcr2091. Epub 2008 May 7.

PMID:
18460216
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer.

Yonemori K, Katsumata N, Noda A, Uno H, Yunokawa M, Nakano E, Kouno T, Shimizu C, Ando M, Tamura K, Takeuchi M, Fujiwara Y.

J Cancer Res Clin Oncol. 2008 Nov;134(11):1199-206. doi: 10.1007/s00432-008-0401-7. Epub 2008 Jun 5.

PMID:
18528707
[PubMed - indexed for MEDLINE]
9.

DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.

Maier S, Nimmrich I, Koenig T, Eppenberger-Castori S, Bohlmann I, Paradiso A, Spyratos F, Thomssen C, Mueller V, Nährig J, Schittulli F, Kates R, Lesche R, Schwope I, Kluth A, Marx A, Martens JW, Foekens JA, Schmitt M, Harbeck N; European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.

Eur J Cancer. 2007 Jul;43(11):1679-86. Epub 2007 Jun 29.

PMID:
17601725
[PubMed - indexed for MEDLINE]
10.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024
[PubMed - indexed for MEDLINE]
Free Article
11.

A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.

Filipits M, Rudas M, Jakesz R, Dubsky P, Fitzal F, Singer CF, Dietze O, Greil R, Jelen A, Sevelda P, Freibauer C, Müller V, Jänicke F, Schmidt M, Kölbl H, Rody A, Kaufmann M, Schroth W, Brauch H, Schwab M, Fritz P, Weber KE, Feder IS, Hennig G, Kronenwett R, Gehrmann M, Gnant M; EP Investigators.

Clin Cancer Res. 2011 Sep 15;17(18):6012-20. doi: 10.1158/1078-0432.CCR-11-0926. Epub 2011 Aug 1.

PMID:
21807638
[PubMed - indexed for MEDLINE]
Free Article
12.

Identification of PTHrP(12-48) as a plasma biomarker associated with breast cancer bone metastasis.

Washam CL, Byrum SD, Leitzel K, Ali SM, Tackett AJ, Gaddy D, Sundermann SE, Lipton A, Suva LJ.

Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):972-83. doi: 10.1158/1055-9965.EPI-12-1318-T. Epub 2013 Mar 5.

PMID:
23462923
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy.

Specht K, Harbeck N, Smida J, Annecke K, Reich U, Naehrig J, Langer R, Mages J, Busch R, Kruse E, Klein-Hitpass L, Schmitt M, Kiechle M, Hoefler H.

Breast Cancer Res Treat. 2009 Nov;118(1):45-56. doi: 10.1007/s10549-008-0207-y. Epub 2008 Oct 17.

PMID:
18925433
[PubMed - indexed for MEDLINE]
14.

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.

Touboul E, Buffat L, Belkacémi Y, Lefranc JP, Uzan S, Lhuillier P, Faivre C, Huart J, Lotz JP, Antoine M, Pène F, Blondon J, Izrael V, Laugier A, Schlienger M, Housset M.

Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):25-38.

PMID:
9989511
[PubMed - indexed for MEDLINE]
15.

Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.

Diel IJ, Solomayer EF, Seibel MJ, Pfeilschifter J, Maisenbacher H, Gollan C, Pecherstorfer M, Conradi R, Kehr G, Boehm E, Armbruster FP, Bastert G.

Clin Cancer Res. 1999 Dec;5(12):3914-9.

PMID:
10632320
[PubMed - indexed for MEDLINE]
Free Article
16.

[Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].

Fodor J.

Magy Onkol. 2009 Mar;53(1):7-14. doi: 10.1556/MOnkol.53.2009.1.2. Hungarian.

PMID:
19318321
[PubMed - indexed for MEDLINE]
Free Article
17.

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N.

N Engl J Med. 2004 Dec 30;351(27):2817-26. Epub 2004 Dec 10.

PMID:
15591335
[PubMed - indexed for MEDLINE]
Free Article
18.

DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy.

Hartmann O, Spyratos F, Harbeck N, Dietrich D, Fassbender A, Schmitt M, Eppenberger-Castori S, Vuaroqueaux V, Lerebours F, Welzel K, Maier S, Plum A, Niemann S, Foekens JA, Lesche R, Martens JW.

Clin Cancer Res. 2009 Jan 1;15(1):315-23. doi: 10.1158/1078-0432.CCR-08-0166.

PMID:
19118060
[PubMed - indexed for MEDLINE]
Free Article
19.

Risk for distant recurrence of breast cancer detected by mammography screening or other methods.

Joensuu H, Lehtimäki T, Holli K, Elomaa L, Turpeenniemi-Hujanen T, Kataja V, Anttila A, Lundin M, Isola J, Lundin J.

JAMA. 2004 Sep 1;292(9):1064-73.

PMID:
15339900
[PubMed - indexed for MEDLINE]
20.

Early detection of recurrent breast cancer using metabolite profiling.

Asiago VM, Alvarado LZ, Shanaiah N, Gowda GA, Owusu-Sarfo K, Ballas RA, Raftery D.

Cancer Res. 2010 Nov 1;70(21):8309-18. doi: 10.1158/0008-5472.CAN-10-1319. Epub 2010 Oct 19.

PMID:
20959483
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk